Behavioral or Solifenacin Therapy for Urinary Symptoms in Parkinson Disease

Clinical trial NCT03149809 · COMPLETED

Trial details

NCT number: NCT03149809
Sponsor: VA Office of Research and Development
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Overactive Bladder Parkinson Disease

Start date: 2018-03-01
Primary completion: 2023-09-08
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.